-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, WCtEhW3YPWvy+WHJUMOJ2DvOO5WvZD8IqDj5KE7ss9RUAQDZkbmqNVz1MpzIv5Dq NKZdso2K03Ai3RYbhDM36w== 0001180469-05-000008.txt : 20050611 0001180469-05-000008.hdr.sgml : 20050611 20050602115138 ACCESSION NUMBER: 0001180469-05-000008 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20001221 FILED AS OF DATE: 20050602 DATE AS OF CHANGE: 20050602 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PHARMACEUTICAL PRODUCT DEVELOPMENT INC CENTRAL INDEX KEY: 0001003124 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 561640186 STATE OF INCORPORATION: NC FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3151 SOUTH 17TH ST CITY: WILMINGTON STATE: NC ZIP: 28412 BUSINESS PHONE: 9102510081 MAIL ADDRESS: STREET 1: 3151 SOUTH 17TH ST CITY: WILMINGTON STATE: NC ZIP: 28412 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MARIO ERNEST CENTRAL INDEX KEY: 0001180469 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-27570 FILM NUMBER: 05872724 BUSINESS ADDRESS: BUSINESS PHONE: (908)580-1200 MAIL ADDRESS: STREET 1: RELIANT PHARMACEUTICALS, LLC STREET 2: 110 ALLEN ROAD CITY: LIBERTY CORNER STATE: NJ ZIP: 07938 4/A 1 edgar.xml PRIMARY DOCUMENT X0202 4/A 2000-12-21 2001-01-09 0001003124 PHARMACEUTICAL PRODUCT DEVELOPMENT INC PPDI 0001180469 MARIO ERNEST 20 GREENHOUSE DRIVE PRINCETON NJ 08540 1 0 0 0 Common Stock 2000-12-21 4 J 0 3700 0 D 822742 I See Footnote (3) Common Stock 2000-12-21 4 J 0 3700 0 D 822742 I See Footnote (3) Common Stock 2000-12-21 4 J 0 3700 0 A 106526 D Common Stock 2000-12-21 4 J 0 3700 0 A 822742 I See Footnote (3) This report is being filed to reflect two transfers from annuity trusts to (1) the Reporting Person and (2) the Reporting Person's spouse on December 21, 2000. This number is reported on a post-split basis; the stock split 2-for-1 on April 27, 2001. The actual number of shares transferred on Dec. 21, 2000 was 1,850 (3,700 post-split). The number of shares directly owned are reported on a post-split basis. The actual number of shares directly held on December 21, 2000 should have been reported as 53,263 (106,526 post-split). The number of shares indirectly owned are reported on a post-split basis. The actual number of shares indirectly held on December 21, 2000 should have been reported as 411,371 (822,742 post-split). Lisa C. Noecker attorney-in-fact for Ernest Mario 2005-06-02 -----END PRIVACY-ENHANCED MESSAGE-----